| Name | Designation | Appointment Date | Status | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dhanashri Girish Gudi
Appointed as Director since March 1995 |
Director | 31-Mar-1995 | Current | ||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Arti Ramkrishna Kolwankar
Appointed as Director since April 1997 |
Director | 01-Apr-1997 | Current | ||||||||||||||||||||||||||||
|
Ramkrishna Harishet Kolwankar
Appointed as Managing Director since October 1985 |
Managing Director | 15-Oct-1985 | Current | ||||||||||||||||||||||||||||
|
Santosh Ramkrishna Kolwankar
Appointed as Director since November 2009 |
Director | 16-Nov-2009 | Current | ||||||||||||||||||||||||||||
People Timeline
Explore the timeline of key personnel in Grindlays Pharmaceuticals Pvt Ltd's leadership journey.
Loading...
Contact Details
- Address Office Number 406, 407, 408, 4Th Floor Swastik Chambers, Cst Road, Chembur, Mumbai Maharashtra, 400071, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 400071
- Country India
- Website grinpharma.com
Frequently Asked Questions
How can I contact Grindlays Pharmaceuticals Pvt Ltd?
You can contact Grindlays Pharmaceuticals Pvt Ltd through their registered address at Office Number 406, 407, 408, 4Th Floor Swastik Chambers, Cst Road, Chembur, Mumbai Maharashtra, 400071, India, or via their website at grinpharma.com. Social media links are also provided where applicable.
Who are the current directors of Grindlays Pharmaceuticals Pvt Ltd?
The current directors of Grindlays Pharmaceuticals Pvt Ltd are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- ARTI RAMKRISHNA KOLWANKAR
- RAMKRISHNA HARISHET KOLWANKAR
- SANTOSH RAMKRISHNA KOLWANKAR
- DHANASHRI GIRISH GUDI
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.